GlassScriptPhysician profile
Lauren Virginia Smith
NPI 1265102990
$1,054.85
in general payments reported to CMS, 2019-2025
15 companies · $230 in 2025
The $230 reported for 2025 was more than what 78% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.30 · 2022: $131 · 2023: $401 · 2024: $279 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $332.26 | 2023-2025 | Enhertu, Injectafer, Datroway |
| Emd Serono, INC. | $211.28 | 2023-2025 | Bavencio |
| Celgene Corporation | $86.86 | 2024 | Abecma |
| Takeda Pharmaceuticals U.S.A., INC. | $79.93 | 2023-2025 | Iclusig |
| Bayer Healthcare Pharmaceuticals INC. | $73.63 | 2022-2023 | |
| Eisai INC. | $61.47 | 2022 | |
| Karyopharm Therapeutics INC. | $49.22 | 2022-2023 | Xpovio |
| Seqirus USA INC | $34.60 | 2025 | Flucelvax |
| Sun Pharmaceutical Industries INC. | $23.69 | 2023 | Odomzo, Yonsa |
| Alexion Pharmaceuticals, INC. | $21.40 | 2023 | Ultomiris |
| G1 Therapeutics, INC. | $20.82 | 2023 | Cosela |
| Kyowa Kirin, INC. | $17.08 | 2022 | |
| Taiho Oncology, INC. | $16.79 | 2024 | |
| Ucb, INC. | $13.30 | 2021 | |
| Aveo Pharmaceuticals, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.